TY  - BOOK
AU  - Barac, Ana
TI  - Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic. [Review]
SN  - 1050-1738
PY  - 2020///
KW  - IN PROCESS -- NOT YET INDEXED
KW  - MedStar Heart & Vascular Institute
KW  - Journal Article
KW  - Review
N2  - Patients with pre-existing cardiovascular disease and risk factors are more likely to experience adverse outcomes associated with the novel  coronavirus disease-2019 (COVID-19). Additionally, consistent reports of cardiac injury and de novo cardiac complications, including possible myocarditis,  arrhythmia, and heart failure in patients without prior cardiovascular disease or significant risk factors, are emerging, possibly due to an accentuated  host immune response and cytokine release syndrome. As the spread of the virus increases exponentially, many patients will require medical care either for  COVID-19 related or traditional cardiovascular issues. While the COVID-19 pandemic is dominating the attention of the healthcare system, there is an unmet  need for a standardized approach to deal with COVID-19 associated and other traditional cardiovascular issues during this period. We provide consensus  guidance for the management of various cardiovascular conditions during the ongoing COVID-19 pandemic with the goal of providing the best care to all  patients and minimizing the risk of exposure to frontline healthcare workers. Copyright (c) 2020. Published by Elsevier Inc
UR  - https://dx.doi.org/10.1016/j.tcm.2020.05.004
ER  -